BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17942605)

  • 1. Dual mechanism of a natural CaMKII inhibitor.
    Vest RS; Davies KD; O'Leary H; Port JD; Bayer KU
    Mol Biol Cell; 2007 Dec; 18(12):5024-33. PubMed ID: 17942605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving a natural CaMKII inhibitor by random and rational design.
    Coultrap SJ; Bayer KU
    PLoS One; 2011; 6(10):e25245. PubMed ID: 21984908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A significant but rather mild contribution of T286 autophosphorylation to Ca2+/CaM-stimulated CaMKII activity.
    Coultrap SJ; Barcomb K; Bayer KU
    PLoS One; 2012; 7(5):e37176. PubMed ID: 22615928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength.
    Barcomb K; Buard I; Coultrap SJ; Kulbe JR; O'Leary H; Benke TA; Bayer KU
    FASEB J; 2014 Aug; 28(8):3810-9. PubMed ID: 24843070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotides and phosphorylation bi-directionally modulate Ca2+/calmodulin-dependent protein kinase II (CaMKII) binding to the N-methyl-D-aspartate (NMDA) receptor subunit GluN2B.
    O'Leary H; Liu WH; Rorabaugh JM; Coultrap SJ; Bayer KU
    J Biol Chem; 2011 Sep; 286(36):31272-81. PubMed ID: 21768120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor.
    Vest RS; O'Leary H; Coultrap SJ; Kindy MS; Bayer KU
    J Biol Chem; 2010 Jul; 285(27):20675-82. PubMed ID: 20424167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitotoxic neuroprotection and vulnerability with CaMKII inhibition.
    Ashpole NM; Hudmon A
    Mol Cell Neurosci; 2011 Apr; 46(4):720-30. PubMed ID: 21316454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-selective and calcium-independent activation of CaMKII by α-actinin.
    Jalan-Sakrikar N; Bartlett RK; Baucum AJ; Colbran RJ
    J Biol Chem; 2012 May; 287(19):15275-83. PubMed ID: 22427672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMKII "autonomy" is required for initiating but not for maintaining neuronal long-term information storage.
    Buard I; Coultrap SJ; Freund RK; Lee YS; Dell'Acqua ML; Silva AJ; Bayer KU
    J Neurosci; 2010 Jun; 30(24):8214-20. PubMed ID: 20554872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection.
    Coultrap SJ; Freund RK; O'Leary H; Sanderson JL; Roche KW; Dell'Acqua ML; Bayer KU
    Cell Rep; 2014 Feb; 6(3):431-7. PubMed ID: 24485660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CaMKII in cerebral ischemia.
    Coultrap SJ; Vest RS; Ashpole NM; Hudmon A; Bayer KU
    Acta Pharmacol Sin; 2011 Jul; 32(7):861-72. PubMed ID: 21685929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for regulation of calmodulin kinase IIalpha by Ca(2+)/calmodulin and autophosphorylation of threonine 286.
    Chin D; Means AR
    Biochemistry; 2002 Nov; 41(47):14001-9. PubMed ID: 12437357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the N-methyl-D-aspartate receptor and calcium/calmodulin-dependent protein kinase IIα signal in the rostral anterior cingulate cortex is involved in pain-related aversion in rats with peripheral nerve injury.
    Gao X; Lin J; Sun L; Hu J; Gao W; Yu J
    Behav Brain Res; 2023 Aug; 452():114560. PubMed ID: 37394125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heart arrhythmia-linked D130G calmodulin mutation causes premature inhibitory autophosphorylation of CaMKII.
    Berchtold MW; Munk M; Kulej K; Porth I; Lorentzen L; Panina S; Zacharias T; Larsen MR; la Cour JM
    Biochim Biophys Acta Mol Cell Res; 2021 Nov; 1868(12):119119. PubMed ID: 34391760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca
    Wong MH; Samal AB; Lee M; Vlach J; Novikov N; Niedziela-Majka A; Feng JY; Koltun DO; Brendza KM; Kwon HJ; Schultz BE; Sakowicz R; Saad JS; Papalia GA
    J Mol Biol; 2019 Mar; 431(7):1440-1459. PubMed ID: 30753871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CaMKII autonomy is substrate-dependent and further stimulated by Ca2+/calmodulin.
    Coultrap SJ; Buard I; Kulbe JR; Dell'Acqua ML; Bayer KU
    J Biol Chem; 2010 Jun; 285(23):17930-7. PubMed ID: 20353941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation status of the NR2B subunit of NMDA receptor regulates its interaction with calcium/calmodulin-dependent protein kinase II.
    Raveendran R; Devi Suma Priya S; Mayadevi M; Steephan M; Santhoshkumar TR; Cheriyan J; Sanalkumar R; Pradeep KK; James J; Omkumar RV
    J Neurochem; 2009 Jul; 110(1):92-105. PubMed ID: 19453375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic activity of CaMKII is not required for its interaction with the glutamate receptor subunit GluN2B.
    Barcomb K; Coultrap SJ; Bayer KU
    Mol Pharmacol; 2013 Dec; 84(6):834-43. PubMed ID: 24056996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of calcium and calmodulin dependent protein kinase II during stimulation of insulin secretion.
    Norling LL; Colca JR; Kelly PT; McDaniel ML; Landt M
    Cell Calcium; 1994 Aug; 16(2):137-50. PubMed ID: 7982264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B.
    Bayer KU; LeBel E; McDonald GL; O'Leary H; Schulman H; De Koninck P
    J Neurosci; 2006 Jan; 26(4):1164-74. PubMed ID: 16436603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.